Core E - Outreach, Recruitment and Education Core
Core E - Outreach, Recruitment and Education Core
批准号:
8676354
负责人:
REISA A. SPERLING
金额:
$16.1万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2019-03-31
关键词:
Alzheimer&aposs DiseaseAmyloidAreaAwarenessBiological MarkersBostonClinicClinicalClinical ResearchClinical TrialsCommitCommunitiesCommunity HealthCommunity Health EducationCommunity OutreachDementiaDiseaseEarly DiagnosisEarly InterventionEarly intervention trialsEducationEnrollmentEvolutionFellowshipFundingHealth ProfessionalHuman ResourcesImageImaging TechniquesImpaired cognitionIndividualIndustryInstitutesLanguageLeadLeadershipMassachusettsMemoryMethodsMetricMissionNeeds AssessmentNeurodegenerative DisordersObservational StudyParticipantPatientsPilot ProjectsPopulationPositron-Emission TomographyPreventionPublic HealthQuestionnairesRecruitment ActivityRegistriesResearchResearch DesignResearch PersonnelResearch Project GrantsRiskSecondary PreventionStagingSymptomsTrainingTraining ProgramsUnderrepresented MinorityUnited States National Institutes of HealthWorkWritingabstractingamyloid imagingbasecareer developmentcohortexperienceimaging modalityimprovedinnovationinterestmeetingsneuroimagingoutreachpre-clinicalprogramspublic educationracial and ethnicresearch studysatisfactionsocioeconomicsvolunteer
中文摘要
外展、招聘和教育核心项目摘要/摘要
在过去的两年中,MADRC的推广、招聘和教育核心已经过渡到新的领导层
多年来,并将其使命重新集中在社区外联和促进快速加入MADRC
附属临床研究。我们的领域朝着AD早期检测和干预的方向发展
对公共教育和招募不同参与者进入生物标志物密集型提出了新的挑战
学习。我们力求发挥领导作用,提高公众对以下问题的认识
参与AD临床研究,并开发关于很早就不断演变的概念的可访问信息
广告。在过去的一个周期中,我们支持非常成功地招聘和保留
纵向队列以及多个MADRC附属临床研究项目和国家多中心
研究,包括ADNI、DIAN、ADCS和行业赞助的临床试验。我们现在已经建立了一个积极主动的
对纵向队列(LC)的需求评估,并支持新的MADRC附属研究和国家
多中心项目。我们正在与临床核心密切合作,以保留纵向队列,
特别是来自代表性不足的少数群体的参与者,并建立一个全面的研究登记处,以
补充LC以确定准备登记的临床正常个体和有症状的患者
在临床研究项目中。我们提出了几个新的计划,以满足我们的多元化招聘需求
中心,包括创新参与者大使计划和与临床核心的合作伙伴关系
新的西班牙语记忆诊所。我们正在将我们的外展范围扩大到当地社区卫生和老年中心,以
增加研究参与者的多样性。我们还在通过一个多样化的
社区咨询委员会,以更好地了解注册参与者的潜在障碍
利用生物标记物和成像程序进行密集的临床试验,
例如无症状AD(A4)二级预防试验中的ADCS抗淀粉样蛋白治疗。我们会
与新提出的神经成像核心以及我们在其他ADC的同事协调,以开发
教育公众和专业人员正确使用PET淀粉样成像的信息材料
以及向研究参与者安全地披露淀粉样蛋白状态信息的方法。我们将实施
评估我们在社区教育项目中的影响的量化指标,并将开发匿名
研究对象满意度问卷,以进一步改善我们研究参与者的体验。我们会留下来
致力于培训年轻的研究人员和临床医生,使他们了解早期发现AD和
并将支持侧重于AD研究进展的教育论坛,包括当地和
在全国范围内,并与每个MADRC核心的教育部门合作,以加强培训
整个中心的计划。
英文摘要
OUTREACH, RECRUITMENT & EDUCATION CORE PROJECT SUMMARY/ABSTRACT
The MADRC Outreach, Recruitment, and Education Core has transitioned to new leadership over the past two
years and has refocused its mission on community outreach and facilitating rapid enrollment into MADRC
affiliated clinical research studies. The evolution of our field towards earlier detection and intervention in AD
presents new challenges for public education and for recruitment of diverse participants into biomarker intensive
studies. We seek to provide leadership in increasing public awareness about the critical importance of
participation in AD clinical research and develop accessible information on the evolving concepts of very early
AD. Over the past cycle, we supported the highly successful recruitment and retention of subjects for the
Longitudinal Cohort as well as multiple MADRC affiliated clinical research projects and national multi-center
studies, including ADNI, DIAN, ADCS and industry sponsored clinical trials. We have now instituted a proactive
needs assessment for the Longitudinal Cohort (LC) and to support new MADRC affiliated research and national
multi-center projects. We are working closely with the Clinical Core on retention of the Longitudinal Cohort,
particularly participants from under-represented minorities, and to build a comprehensive Research Registry to
supplement the LC in identifying clinically normal individuals and symptomatic patients who are ready to enroll
in clinical research projects. We propose several new programs to serve the diversity recruitment needs of our
Center, including an innovative Participant Ambassador Program and partnership with the Clinical Core on the
new Spanish Memory Clinic. We are expanding our outreach to local community health and senior centers to
increase the diversity of research participants. We are also reinvigorating our partnership with a diverse
Community Advisory Board to better understand the potential barriers to enrolling participants from
under-represented minority communities into intensive clinical trials with biomarker and imaging procedures,
such as the ADCS Anti-Amyloid Treatment in Asymptomatic AD (A4) secondary prevention trial. We will
coordinate with the newly proposed Neuroimaging Core, and our colleagues at other ADCs, to develop
informative materials to educate the public and professionals about the appropriate use of PET amyloid imaging
and methods to safely disclose information about amyloid status to research participants. We will implement
quantitative metrics to assess our impact in community education programs and will develop anonymous
subject satisfaction questionnaires to further improve the experience of our research participants. We remain
committed to training young investigators and clinicians about the importance of early detection of AD and
related dementias, and will support educational forums focused on advances in AD research, both locally and
nationally, as well as working with the educational components of each of the MADRC cores to enhance training
programs across the Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core F - Neuroimaging Core
-
批准号:8676355
-
项目类别:
-
资助金额:$17.59万
-
财政年份:2014
-
负责人:REISA A. SPERLING
-
依托单位:
Impact of Amyloid on the Aging Brain
-
批准号:7871772
-
项目类别:
-
资助金额:$217.54万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Detection of early cognitive change: Linking to clinically meaningful outcomes (Project 4)
-
批准号:10541814
-
项目类别:
-
资助金额:$27.49万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Mentoring Imaging Research in Early AD
-
批准号:8306146
-
项目类别:
-
资助金额:$13.96万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Core A: Administrative Core
-
批准号:10541799
-
项目类别:
-
资助金额:$27.1万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Impact of Amyloid on the Aging Brain
-
批准号:8286907
-
项目类别:
-
资助金额:$208.77万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Mentoring Imaging Research in Early AD
-
批准号:9032789
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Mentoring Imaging Research in Early AD
-
批准号:7993672
-
项目类别:
-
资助金额:$13.75万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Impact of Amyloid on the Aging Brain
-
批准号:8111713
-
项目类别:
-
资助金额:$210.84万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Impact of Amyloid on the Aging Brain
-
批准号:8686697
-
项目类别:
-
资助金额:$205.29万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Impact of Amyloid on the Aging Brain
-
批准号:8490270
-
项目类别:
-
资助金额:$195.86万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Mentoring Imaging Research in Early AD
-
批准号:8720642
-
项目类别:
-
资助金额:$13.96万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Mentoring Imaging Research in Early AD
-
批准号:8141145
-
项目类别:
-
资助金额:$13.96万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Mentoring Imaging Research in Early AD
-
批准号:8512634
-
项目类别:
-
资助金额:$13.96万
-
财政年份:2010
-
负责人:REISA A. SPERLING
-
依托单位:
Mentoring Imaging Research in Early AD
-
批准号:9902271
-
项目类别:
-
资助金额:$13.07万
-
财政年份:2009
-
负责人:REISA A. SPERLING
-
依托单位:
TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DISEASE
-
批准号:7719312
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2008
-
负责人:REISA A. SPERLING
-
依托单位:
ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI)
-
批准号:7719362
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2008
-
负责人:REISA A. SPERLING
-
依托单位:
ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI)
-
批准号:7607420
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2007
-
负责人:REISA A. SPERLING
-
依托单位:
TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DISEASE
-
批准号:7607372
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2007
-
负责人:REISA A. SPERLING
-
依托单位:
REDUCING HOMOCYSTEINE TO SLOW COGNITIVE DECLINE IN ALZHEIMER'S DISEASE
-
批准号:7379246
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2006
-
负责人:REISA A. SPERLING
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: